Ai and Data in Pharma
& Healthcare Summit

Boston, USA

23-24 October 2025

Panel sponsor

Request agenda

Standard registration fee

EUR: 3.999,-
Register
KEY TOPICS:
  • Leveraging Data and Technology to create value across Clinical Development Life Cycle
  • Scaling AI for Drug Discovery
  • LLMs for Pharma: How LLM is being used in Drug Development
  • Early experience with Agentive AI
  • Accelerating execution of RWE and its challenges
  • GenAI community enablement
  • Gen AI in Clinical Trials – success and learnings
  • GPT Agents: The future of Custom AI
  • Unlocking the Power of Longitudinal Data
  • Regulated Data, Digital and AI capabilities
  • Pharma and Patients Analytics – data driven decision making
  • Fostering Innovation in Digital Health and MedTech
SPEAKERS AT THE SUMMIT


Ferhat Yilmaz
Novo Nordisk
USA
Associate Director Data Science and Ai


Valerie Alleger
Johnson & Johnson Innovative Medicine
USA
Senior Director, Global Data Science


Jeremy Zhang
Gilead Sciences
USA
Senior Director, Data Science


Gunjan Aggarwal
Novartis
USA
Executive Director – Insights & Decision Science


Victoria Gamerman
Boehringer Ingelheim
USA
Global Head of Digital Transformation


Naveed Afzal
Takeda
USA
Head of Data Science


Ali Soltani Tehrani
AstraZeneca
USA
Associate Director of Data Science


Nadia Tantsyura
Merck
USA
Director, US Omnichannel OME Activation Director


Vitaly Doban
Ipsen
USA
VP, Head of Data & Insights Generation


Adam Mico
Moderna
USA
Principal, Data and Analytics Strategist


Amir Tahmasebi
BD
USA
Director, Computer Vision and NLP


Regis A. James
Regeneron
USA
Associate Director Data Science


Dana Vuzman
Novo Nordisk
USA
Sr Director, Data & Analytics Engineering